Insulin glargine and lixisenatide Subcutaneous and Lortuss EX
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Lortuss EX and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: codeine / guaifenesin / pseudoephedrine
Brand name: Ambifed CD, Biotussin DAC, Cheratussin DAC, Guaifen DAC, Lortuss EX, Maxifed-G CD, Nucofed Pediatric Expectorant, Tricode GF, Tusnel C, Virtussin DAC, Virtussin DAC
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Lortuss LQ
- Insulin glargine and lixisenatide Subcutaneous-Loryna
- Insulin glargine and lixisenatide Subcutaneous-Lorzone
- Insulin glargine and lixisenatide Subcutaneous-Lorzone Tablets
- Insulin glargine and lixisenatide Subcutaneous-Losartan
- Insulin glargine and lixisenatide Subcutaneous-Losartan and Hydrochlorothiazide
- Lortuss EX-Insulin glargine, recombinant Subcutaneous
- Lortuss EX-Insulin glulisine
- Lortuss EX-Insulin Glulisine (Cartridges and Pens)
- Lortuss EX-Insulin Glulisine (Vials)
- Lortuss EX-Insulin glulisine Subcutaneous
- Lortuss EX-Insulin human inhaled Inhalation